Bicycle Therapeutics plcBicycle Therapeutics plcBicycle Therapeutics plc

Bicycle Therapeutics plc

No trades
See on Supercharts
Market capitalization
‪930.53 M‬USD
−5.15USD
‪−181.36 M‬USD
‪27.08 M‬USD
‪41.93 M‬
Beta (1Y)
1.75

About Bicycle Therapeutics plc

CEO
Kevin Lee
Headquarters
Cambridge
Employees (FY)
284
Founded
2009
ISIN
US0887861088
FIGI
BBG00P0YWPK6
Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.